Description

3,8(2H,5H)-Indolizinedione,1,8A-Dihydro-6-Methyl-,(S)-(9Ci) is a chiral indolizinedione derivative, a specialized heterocyclic compound of significant interest in advanced organic synthesis. Its value lies in its role as a key chiral building block or intermediate for the development of novel pharmaceuticals and bioactive molecules. This high-purity intermediate is essential for research and development chemists in the pharmaceutical, agrochemical, and fine chemical industries seeking to create enantiomerically pure compounds.

Application

• Pharmaceutical Intermediate: Serves as a critical chiral scaffold in the synthesis of potential active pharmaceutical ingredients (APIs), particularly for central nervous system (CNS) or anti-infective drug candidates.
• Asymmetric Synthesis: Utilized as a starting material or advanced intermediate in asymmetric catalytic reactions to construct complex molecular architectures with high stereoselectivity.
• Medicinal Chemistry Research: Employed in structure-activity relationship (SAR) studies and library synthesis for drug discovery programs targeting novel biological pathways.
• Agrochemical Development: Acts as a precursor in the research and synthesis of new, enantiomerically pure pesticides or herbicides.
• Fine Chemical Synthesis: Used in the production of specialty chemicals, chiral ligands for catalysis, or advanced materials requiring specific stereochemistry.
• Academic & Institutional Research: A valuable compound for methodological development in organic chemistry and for studying heterocyclic reaction mechanisms.

Basic Information

Product Name	3,8(2H,5H)-Indolizinedione,1,8A-Dihydro-6-Methyl-,(S)-(9Ci)
CAS No.	175846-69-2
Molecular Formula	C9H11NO2
Molecular Weight	165.19 g/mol
Synonyms	(S)-1,8a-Dihydro-6-methyl-3,8(2H,5H)-indolizinedione; (S)-6-Methyl-1,8a-dihydro-3,8-indolizinedione; (S)-6-Methyl-1,8a-dihydroindolizine-3,8-dione; (S)-6-Methyl-1,8a-dihydro-2H,5H-indolizine-3,8-dione; (S)-6-Methyl-1,8a-dihydro-3,8(2H,5H)-indolizinedione; Chiral 6-methylindolizinedione derivative; (S)-enantiomer of 175846-69-2
EINECS	Contact for details

Quality Control

Our 3,8(2H,5H)-Indolizinedione,1,8A-Dihydro-6-Methyl-,(S)-(9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including chiral purity verification by HPLC, to ensure it meets the high standards required for research and development applications. Certificates of Analysis (COA) detailing identity, purity, and chiral excess are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This compound may be light-sensitive and should be handled under an inert atmosphere for long-term stability if specified.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Chiral Purity (Chiral HPLC)	≥ 98.0% ee
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.